Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales13 06215 06714 57115 89215 36815 874
EBITDA4 4577 1997 6297 9037 4437 721
Operating profit (EBIT)4 2266 9147 2457 6397 2397 536
Pre-Tax Profit (EBT)------
Net income-1 6313 683-1 220-6 49933,1856
P/E ratio-34,731,2-66,2-8,82-102-486
EPS ( $ )-7,4210,0-3,17-20,0-1,73-0,36
Dividend per Share ( $ )---2,862,903,05
Yield---1,63%1,65%1,73%
Reference price ( $ )257.41312.5210.01176.05176.05176.05
Announcement Date02/18/2015
11:30am
02/22/2016
12:30pm
02/08/2017
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt15 29341 62119 54324 90223 20319 842
Finance------
Operating income (EBITDA)4 4577 1997 6297 9037 4437 721
Leverage
(Debt/EBITDA)
3,43x5,78x2,56x3,15x3,12x2,57x
Capital Expenditure239455331301309306
Book Value Per Share (BVPS)107 $194 $199 $200 $193 $187 $
Cash Flow per Share10,7 $11,7 $3,64 $18,9 $15,8 $17,1 $
Announcement Date02/18/2015
11:30am
02/22/2016
12:30pm
02/08/2017
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 58 551 M$ -
Entreprise Value (EV) 83 454 M$ 81 754 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 3,68x 3,81x
EV / Revenue 5,25x 5,32x
EV / EBITDA 10,6x 11,0x
Yield (DPS / Price) 1,63% 1,65%
Price to book (Price / BVPS) 0,88x 0,91x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 48,1% 47,1%
operating Leverage (Delta EBIT / Delta Sales) 0,60x -1,59x
Net Margin (Net Profit / Revenue) -40,9% 0,22%
ROA (Net Profit / Asset) 2,50% 3,21%
ROE (Net Profit / Equities) 6,00% 6,33%
Rate of Dividend -14,3% -168%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,89% 2,01%
Cash Flow / Sales 39,6% 34,2%
Capital Intensity (Assets / Sales) -16,4x 0,07x
Financial Leverage (Net Debt / EBITDA) 3,15x 3,12x
EPS & Dividend